Hepatitis Clinical Trials

Showing 21-40 of 1,819 trials

A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of SNP-610 for the Treatment of Patients With Non-alcoholic Steatohepatitis

NCT03468556

The primary objective of the study is to compare the changes in serum ALT level among patients with non-alcoholic steatohepatitis (NASH) following 3-month treatment of 800 mg SNP-610 or the placebo. The secondary objectives will be to compare the changes in liver fat fraction, other liver function tests, cytokeratin-18 (CK-18) fragment level and adverse event / serious adverse event rates among the interventional and placebo arms.

NASH - Nonalcoholic Steatohepatitis

Sinew Pharma Inc.80 participantsStarted Apr 2026

COMPLETEDNA

KP-Led Same Day HCV Test and Treat Study

NCT05479760

This is a Hybrid design to primarily assess effectiveness, and to secondarily observe and collect data on the implementation of the service. This will allow the assessment of health-related outcomes and implementation outcomes to facilitate dissemination and replication if proven to be successful in other CBOs in Thailand, regionally, and globally.

HCV, HIV

Institute of HIV Research and Innovation Foundation, Thailand200 participantsStarted Aug 2023

Bangkok, Bangkapi, Thailand • Pathum Wan, Bangkok, Thailand • Bangkok, Building 3, Patpong, Surawong Road, Thailand +1 more locations

A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of SNP-610 for the Treatment of Patients With Non-alcoholic Steatohepatitis

KP-Led Same Day HCV Test and Treat Study

Related Searches

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection

Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic(PK/PD) Profile of ACT500 in Metabolic Dysfunction-Associated Steatotic Liver Disease(MASLD)

Appalachian Partnership to Reduce Disparities (Aim 2)

A Multi-country, Cross-sectional Quantitative Study Exploring Awareness, Understanding, and Perceptions of the Relation Between Cardiorenal Metabolic Conditions and MASLD/MASH Among Healthcare Providers, People With MASLD/MASH, and At-risk Population

Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRE

Entecavir Resistance-Associated Mutations in Chronic HBV Patients in Turkey (STREAM Study)

miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 Trial

Hepatic and Splenic Microcirculatory Perfusion for Ruling Out High-Risk Varices in Patients With Hepatitis B-Related Cirrhosis

Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV Infection

ePro Diary - HDV ( MACROLIVER )

Implementing Low-Barrier HCV Treatment in a Jail Setting

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

Identification of Liver Fibrosis Biomarkers

The COMBAT HBV Feasibility Trial

"Pregnancy and Viral Infections: Impact on Pregnant Women and Their Children. French Prospective Cohort"

Safety, Tolerability, and Pharmacokinetics of ACT500 in Healthy Adult Participants

Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients

A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR)